Posts by Sandra Ansanay-Alex
An electronic implant helps a bedridden patient to walk again
Researchers at the NeuroRestore research center in Lausanne Switzerland helped a patient suffering from a neurogenerative disease to leave her bed without fainting. Jocelyne Bloch, neurosurgeon at the CHUV and professor at the UNIL in Lausanne Switzerland, and Grégoire Courtine, professor in neurosciences at the EPFL, and their teams, have enabled a 48-year-old woman…
Read MoreNeurosoft Bioelectronics raised CHF 3 Million
The Geneva-based company developed soft and flexible electrodes which can seamlessly interface with the brain Neurosoft Bioelectronics, an early-stage company developing tools for unmet needs in epilepsy and tinnitus, was awarded nearly $3 million, from the SERI-Funded European Innovation Council Accelerator Grant and a share of the $165 000 through the European Research Council…
Read MoreWestern Switzerland, paradise for Life Sciences Companies
18 new foreign life sciences companies settled in our region in 2021 Last year, according to GGBa’s annual report, 86 foreign companies established new business operations in Western Switzerland, with the support of GGBa and the cantonal economic development agencies of Bern, Fribourg, Vaud, Neuchâtel, Geneva, and Valais. Among them, 18 companies are active…
Read MoreTech4Eva 2022 cohort
13 growth-stage startups and 15 early-stage start-ups and projects have been selected for the 2022 program. Tech4Eva is an EPFL initiative that aims at creating a long-term impact for FemTech startups and a global FemTech Community. The 2022 international cohort, selected from a total of 124 applications, is mainly represented by Swiss-based, USA-based and…
Read MoreDayOne Accelerator 2.0
Three programmes that enable the growth of global healthcare and medtech startups at various stages of their development Digital Health Nation Digital Health Nation is an NTN Innovation Booster powered by Innosuisse that aims at transforming and improving the Swiss healthcare system, but more importantly, patients’ lives. Day One helps the applicants with all the…
Read MoreNanolive raises US $ 20 million
The Swiss company is a pioneer in the development of live-cell imaging, and digital analytical solutions The swiss leading live-cell imaging and analysis company, announces that it has successfully completed the initial closing of US $20 million in the Series C-1 equity financing round of investment, led by a US-based and NASDAQ listed life science…
Read MoreVenture Leaders Medtech Team 2022
Ten startups have been chosen by a jury of investors as the Swiss National Startup Team for Venture Leaders Medtech 2022. The designated entrepreneurs fly to Boston for a one-week roadshow in June 2022 to accelerate their expansion into the US market and build an exceptional business network through meetings with top-notch investors…
Read MoreCafé Innovation | HUG | 5 April
Innovation Café, Tuesday 5 April , 2022 from 12:45 to 1:45 pm. Theme: “Personalized cancer immunotherapy in Geneva: from the laboratory to Phase II, the journey of MaxiVAX”. Presented by Pr Nicolas Mach, Oncology Department of the HUG & Faculty of Medicine of the University of Geneva, co-founder of the startup MaxiVAX. Where: Centre de…
Read MoreA MEG plateform at Campus Biotech in 2022
A new device for brain research at the Campus Biotech Next summer, the Human Neuroscience Platform (HNP) at Campus Biotech will acquire and install a new Magnetoencephalography (MEG). The new MEGIN Triux neo will integrate the already existing MEEG-BCI MRI facility. Magnetoencephalography (MEG) is a non-invasive imaging technique for investigating human brain activity. Dr…
Read MoreCompletely locked-in man uses brain-computer interface to communicate
Researchers at the Wyss Center Geneva created a device and a computer program to decode brain signals Completely paralyzed and unable to speak, a 30-year-old man was able to speak with its caregivers and his family. He even managed to ask his 4-year-old son : “Do you want to watch Disney’s Robin Hood with…
Read More